MiniMed Group, Inc.
For the period ended Jul 31, 2026. Filed Sep 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2026 · Filed Sep 8, 2026
MMED$17.36-2.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at July 3, 2026 and April
CONDENSED CONSOLIDATED BALANCE SHEETS
| (in millions) | July 31, 2026 | April 24, 2026 |
|---|---|---|
| ASSETS · (Unaudited) | ||
| Current assets: | ||
| Cash and cash equivalents | $207 | $298 |
| Accounts receivable, less allowance for credit losses of $28 and $26, respectively | 180 | 200 |
| Due from Medtronic | 602 | 455 |
| Inventories | 356 | 341 |
| Other current assets | 72 | 54 |
| Total current assets | 1,417 | 1,348 |
| Property, plant, and equipment, net | 736 | 711 |
| Goodwill | 2,255 | 2,256 |
| Other intangible assets, net | 100 | 107 |
| Tax assets | 58 | 61 |
| Other assets | 152 | 147 |
| Total assets | $4,718 | $4,630 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $251 | $163 |
| Due to Medtronic | 178 | 137 |
| Accrued compensation | 126 | 163 |
| Accrued rebates | 42 | 45 |
| Other accrued expenses | 185 | 194 |
| Total current liabilities | 782 | 702 |
| Other liabilities | 316 | 317 |
| Total liabilities | 1,098 | 1,019 |
| Commitments and contingencies (Note 12) | ||
| Stockholders’ equity: | ||
| Common stock, par value $0.01, 1,000,000,000 shares authorized, 281,205,548 and 280,819,988 shares issued and outstanding, at July 31, 2026 and April 24, 2026, respectively | 3 | 3 |
| Preferred stock, par value $0.01, 100,000,000 shares authorized, none issued and outstanding | — | — |
| Additional paid-in capital | 3,747 | 3,736 |
| Accumulated deficit | (116) | (116) |
| Accumulated other comprehensive income | (14) | (12) |
| Total stockholders’ equity | 3,620 | 3,611 |
| Total liabilities and stockholders’ equity | $4,718 | $4,630 |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Common Stock · Additional Paid-in Capital · RetainedEarnings · AccumulatedOtherComprehensiveLoss · Total Stockholders’ Equity | ||||||
|---|---|---|---|---|---|---|
| ($ in millions) (shares in thousands) · Shares · Par Value | ||||||
| April 24, 2026 | 280,820 | $3 | $3,736 | $(116) | $(12) | $3,611 |
| Net income (loss) | — | — | — | — | — | — |
| Foreign exchange translation adjustment | — | — | — | — | (2) | (2) |
| Issuance of shares under stock purchase and award plan | 180 | — | 2 | — | — | 2 |
| Stock-based compensation | — | — | 10 | — | — | 10 |
| Vesting of restricted stock units, net of shares withheld for taxes | 206 | — | (2) | — | — | (2) |
| July 31, 2026 | 281,206 | $3 | $3,747 | $(116) | $(14) | $3,620 |
| ParentCompanyInvestment | AccumulatedOtherComprehensiveIncome | Total Parent Company Equity | |
|---|---|---|---|
| (in millions) | |||
| April 25, 2025 | $3,328 | $3 | $3,330 |
| Net loss | (16) | — | (16) |
| Net transfers from Parent | 212 | — | 212 |
| Other comprehensive income | — | 11 | 11 |
| July 25, 2025 | $3,524 | $13 | $3,537 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.